Alteration of the pharmacokinetics of small proteins by iodination

Biopharmaceutics and Drug Disposition

Volumn 17, Issue 9, 1996, Pages 761-774

  Bauer, Robert J ^a   Leigh, Scott D ^a   Birr, Cynthia A ^a   Bernhard, Susan L ^a   Fang, Maria ^a   Der, Ken ^a   Ihejeto, Nneka Ottah ^a   Carroll, Stephen F ^a   Kung, Ada H C ^a  

^a XOMA Corporation   (United States)

Author keywords

iodine; pharmacokinetics; protein; radiolabel

Indexed keywords

IODINE 125; RECOMBINANT PROTEIN;

ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRAVENOUS DRUG ADMINISTRATION; IODINATION; MALE; NONHUMAN; OXIDATION; PHARMACOKINETICS; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD BACTERICIDAL ACTIVITY; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; MEMBRANE PROTEINS; MOLECULAR WEIGHT; OXIDATION-REDUCTION; RABBITS; RATS; RECOMBINANT PROTEINS;

EID: 0029802560     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199612)17:9<761::AID-BDD992>3.0.CO;2-Z     Document Type: Article

References (21)

1. 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice. Cancer Res., 49, 1752-1757 (1989).
2. 111In. Cancer Res., 47, 1149-1154 (1987).
3. 125I-interleukin-2 in mice. Int. J. Immunopharmacol., 11, 411-416 (1989).
4. 125I-containing acylating agent. Biochem. J., 133, 529-539 (1973).
5. 2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest., 90, 1122-1130 (1992).
6. H. Gazzano-Santoro, J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss and P. J. Conlon, High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipolysaccharide. Infect. Immun., 60, 4754-4761 (1992).
7. K. Meszaros, J. B. Parent, H. Gazzano-Santaro, R. Little, A. Horwitz, T. Parsons, G. Theofan, L. Grinna, J. Weickmann, P. Elsbach, J. Weiss and P. J. Conlon, A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leucocyte responses by LPS. J. Leuk. Biol., 54, 558-563 (1993).
8. F. R. Kohn, W. S. Ammons, A. Horwitz, L. Grinna, G. Theofan, J. Weickmann and A. H. C. Kung, Protective effect of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in experimental endotoxemia. J. Infect. Dis., 168, 1307-1310 (1993).
9. 23 in animals challenged with live bacteria. International Conference on Endotoxins, Amsterdam IV, Amsterdam, August 1993, O.22.
10. W. S. Ammons and A. H. C. Kung, Recombinant amino terminal fragment of bactericidal/ permeability-increasing protein prevents hemodynamic responses to endotoxin. Circ. Shock, 41, 176-184 (1993).
11. 23). J. Biol. Chem., 269, 1865-1872 (1994).
12. A. H. C. Kung, S. F. Carroll, D. M. Fishwild, E. A. Saria, M. L. White and P. Trown, Preclinical evaluations of an immunotoxin. In Therapeutic Proteins, A. H. C. Kung, R. A. Baughman and J. W. Larrick (Eds), Freeman, New York, 1993, pp. 141-163.
13. P. W. Gray, G. Flaggs, S. R. Leong, R. J. Gumina, J. Weiss, C. E. Ooi and P. Elsbach, Cloning of the cDNA of a human neutrophil bactericidal protein. J. Biol. Chem., 264, 9505-9509 (1989).
14. G. M. Studnicka, S. Soares, M. Better, R. E. Williams, R. Nadell and A. H. Horwitz, Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues. Protein Eng., 7, 805-814 (1994).
15. M. Better, S. L. Bernhard, R. E. Williams, S. D. Leigh, R. J. Bauer, A. H. C. Kung, S. F. Carroll and D. M. Fishwild, T cell-targeted immunofusion proteins from E. coli. J. Biol. Chem., 270, 14951-14957 (1995).
16. M. L. White, J. K. Ma, C. A. Birr, P. W. Trown and S. F. Carroll, Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA. J. Immunol. Methods, 167, 227-235 (1994).
17. N. Gibaldi and D. Perrier, Pharmacokinetics, 2nd Edn, Dekker, New York, 1982, Ch. 2.
18. W. M. Hunter, Radioimmunoassay Methods: European Workshop, K. E. Kirkham, and W. M. Hunter (Eds), Churchill Livingstone, Edinburgh and London, 1971, pp. 3-23.
19. J. F. Eary, K. A. Krohn, R. Kishore and W. B. Nelp, Radiochemistry of halogenated antibodies. In Antibodies in Radiodiagnosis and Therapy, M. R. Zalutsky (Ed.), Chemical Rubber Company, Boca Raton, FL, 1989, pp. 83-102.
20. M. R. Zalutsky, Radioiodination of antibodies: chemical aspects. In Radiolabeled Monoclonal Antibodies for Imaging and Therapy, S. C. Srivastava (Ed.), Plenum, New York, 1988, pp. 195-214.
21. M. M. Campbell and G. Johnson, Chloramine T and related N-halogeno-N-metallo reagents. Chem. Rev., 78, 65-79 (1978).